Nottingham Spirk | Insights

Research led by Akron Children’s Hospital finds that pro2cool’s hypothermic therapy reduces symptom severity after concussion...

TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool® Device for the Treatment of Concussions CLEVELAND —...

Regulations in medical device production are costly but necessary. They are established by commissions like the FDA and EPA t...

Nottingham Spirk’s Director of Insights Amanda Beacher was quoted by Clinical Trials Arena regarding the FDA’s new guidance o...

Sterifre Medical Granted EPA Registration for Automated, Point of Care Disinfectant System to Help Combat COVID-19 and Other ...

TecTraum’s pro2cool provides revolutionary point-of-care treatment for concussions CLEVELAND — (BUSINESS WIRE) — TecTraum Inc...

Rachel Abbey McCafferty | Crain’s Cleveland Business When Washington-based Sterifre Medical Inc.’s new disinfection system co...

Excerpt from the Qmed Article: While working a Case Western Reserve University, Yoram Rudy, PhD had the idea for a game-chang...

INDIANAPOLIS (November 13, 2014) — Ohio was well represented at the Forbes Reinventing America Summit. Featured speakers incl...

NorTech Innovation Award received by CardioInsight and Nottingham Spirk. NorTech recognizes companies in Northeast Ohio for t...

Nottingham Spirk medical device partner CardioInsight was featured on August 19, 2012, in the Cleveland Plain Dealer as part ...

Innovation is a messy, unpredictable process. And creativity and new ideas need time to germinate. But time is often an unaff...

The ViewRay MRI System, a client of Nottingham Spirk, has received clearance from the U.S. Food and Drug Administration. Draw...

The Spark